effects on feeding, glucose, and pancreatic hormones in rhesus monkeys. PHYSIOL BEHAV 30(4) [509][510][511][512][513][514][515][516][517][518] 1983.--The effects of cholecystokinin on feeding, and on plasma glucose and pancreatic hormone responses to a mixed-meal were determined in lean rhesus monkeys. Following an overnight fast the octapeptide of cholecystokinin (CCK-8) was administered intravenously over a 6 minute period coincident with the initiation of free feeding or an intragastric infusion of a mixed liquid diet. CCK-8 inhibited feeding and delayed the plasma glucose and insulin response to a mixed-meal. The threshold for the feeding effect ranged from 30 to 120 ng/kg/min across monkeys and did not extend beyond 15 minutes of the start of the CCK infusion. The delays in plasma glucose and insulin were not dependent on rate or amount of food entering the stomach. Further, there were no alterations from basal levels in plasma glucose or insulin prior to the onset of CCK-induced feeding inhibition. There was no evidence that CCK-8 stimulated insulin release, nor was the usual close relationship between plasma glucose and insulin levels in response to a mixed-meal changed by CCK-8.
Rhesus monkeys (Macaca mulatta)
PERIPHERAL intravenous infusions of the exogenous synthetic octapeptide of the brain-gut peptide, cholecystokinin (CCK-8) have been shown to suppress feeding in many animal species, including man [1, 3, 6, 9, l 1, 26] . In general, this reduction in intake is food-specific and free of apparent clinical and sub-clinical distress [1, 3, 6, I1, 12] . The degree of feeding suppression appears to be dependent upon multiple factors, including the amount of CCK infused and the length of the infusion, as well as the length of the food deprivation period preceding each experiment [21, 26] . With few exceptions, the nature of the CCK-induced feeding effect has been described as a rapid, but limited decrease in the length of the meal [l, 6, 9, 11] . In hungry pigs, Anika, Houpt and Houpt demonstrated a rapid threshold type on-off interruption of a meal [1] . CCK did not alter the initial feeding rate in rats orman [9, 11, 21] .
The present study examined the effect of short duration intravenous infusions of CCK-8, at varying doses, on the feeding behavior of rhesus monkeys using a feeding system which allows precise monitoring of food intake and pattern.
We also sought further clarification of CCK-8's effects on the endocrine pancreas. Jensen and associates [10] were unable to stimulate insulin or glucagon release from an isolated pancreas preparation with CCK-8 infused within probable physiological levels. On the other hand, Rouiller and others [23] using intact, anesthetized dogs, administered intravenous CCK-8 and observed increased pancreatic vein and inferior vena cava levels of plasma insulin and glucagon. An indirect role of CCK could be associated with the pre-and post-absorption alterations in the plasma levels of glucose and insulin which have been purported to play significant roles in moment to moment appetite regulation [14] . In addition to the reported effects on plasma glucose and insulin, exogenous CCK-8 has been found to significantly elevate pancreatic polypeptide levels [15] . Further, McLaughlin and Baile [17] have demonstrated that intraperitoneal injections of the pancreatic polypeptide decreased food intake in lean mice.
The present experiments in monkeys examined the effects of intravenous CCK-8 on the levels of plasma glucose, insulin, glucagon, and pancreatic polypeptide in response to an oral or intragastrically infused mixed meal. Furthermore, these experiments sought to identify any association between effects of CCK-8 on feeding behavior and the changes across time in mixed-meal stimulated plasma levels of glucose and pancreatic hormones.
METHOD Five young adult male rhesus monkeys (Macaca mulatta)
weighing from six to nine kg were studied. The monkeys were accustomed to three-tiered primate restraint chairs and were housed in a temperature controlled room (22°C) with a 12-hour light/dark cycle (lights on at 0700 hr). Each monkey was accustomed to an eight hour/day feeding regimen (0800 to 1600 hours), and a completely balanced liquid diet (Ensure ©, Ross Laboratories) which contains 1.06 kcal/ml with 14% of the calories as protein, 31.5% fat, and 54.5% carbohydrate. The liquid diet was delivered via a suckingactivated automated feeding system designed to provide each monkey with free access to food during the daily eight hour feeding period, while at the same time permitting microcomputer recording of detailed patterns of ingestion [25] , including meal size (kcal), meal duration (seconds), and inter-meal interval (minutes). Each meal was defined as a period of sustained feeding (minimum amount 20 kcal) separated from the next such period by at least five minutes, and the period of separation was defined as the inter-meal interval (IMI). Water was available ad lib, 24 hr/day.
Following adaptation to the laboratory, restraint, liquid diet and feeding system, each monkey was surgically implanted with silastic intravenous and intragastric cannulas. The intravenous cannulas (1 mm ID, 2.2 mm OD) were inserted into the internal or external jugular veins, and passed so that the tips were located in the superior vena cava, just above the atrium, or were inserted via the femoral veins to the inferior vena cava. Two intravenous cannulas were used to allow simultaneous infusion and withdrawal. The cannulas were kept patent by continuous infusion of heparinized isotonic saline (4 U/ml) at a rate between 25-50 ml/24 hour period. An intragastric cannula (1.2 mm ID, 2.4 mm OD) was placed in the body of the stomach. Following surgery, all experiments were delayed until the animal resumed feeding at levels approximating those preceding surgery.
In all experiments the synthetic sulphated C-terminal octapeptide of cholecystokinin (CCK-8) (Kinevac, Squibb) was mixed with distilled water to a concentration of 1 /xg/ml. Each experimental dose was mixed with an isotonic saline carrier to equalize the volumes infused, and the flow rate of a Harvard pump was adjusted to infuse the solution at a constant rate of 4.75 ml/min. Saline controls of equal volume were infused at the same rate. Each infusion lasted exactly six minutes. CCK doses ranged from 15 to 120 ng/kg/min, and were administered in random order, with all experiments conducted on separate days.
The plasma glucose, insulin (IRI), glucagon (IRG) and pancreatic polypeptide (PP) responses to six minute intravenous (IV) infusions of CCK-8, administered simultaneously with either the initiation of free feeding or the initiation of an intragastrie mixed-meal infusion, were determined. The time courses of these responses were followed from immediately prior to the start of the CCK-8 infusion (following a 16-hour overnight fast) to 120 minutes. Blood samples were withdrawn immediately before and at intervals of 5, 10, 20, 30, 40, 60 and 120 min from the start of the mixed meal challenge and IV infusion of CCK. Two milliliters of a mixture of blood and heparin solution were withdrawn to clear the cannula dead space followed by the removal of blood samples of three ml each. The dead space fluid was returned to the animal after each sample was withdrawn. Blood samples were placed in ice in sterile heparinized tubes and centrifuged at 2000 RPM for six minutes, within 20 minutes of the draw. The plasma was aliquoted into appropriate assay and storage tubes and frozen at -20°C. The residual blood cells were maintained in sterile containers, reconstituted with bacteriostatic saline and returned to the monkey at the completion of each study. Plasma levels of glucose were measured by the hexokinase and glucose-6-phosphate dehydrogenase method of Slein [24] . Double-antibody radioimmunoassays were used to determine plasma IRI [8] , IRG [22] and PP [4] levels.
Monkeys were not disturbed during the sample collection period and were observed systematically every three minutes for three seconds through a one-way mirror during the first 45 minutes of the experimental period. Behavioral rating scales were used to record these observations, and included sleeping, resting, drinking, eating, sickness behavior and non-ingestive activity. Sleeping behavior was defined as no observable movement, head back and relaxed, and eyes closed; resting as no observable movement, head back and eyes partially closed; feeding as sucking or licking food spout; drinking as licking or sucking water spout; sickness behavior as restlessness, irritability, retching or vomiting; and non-ingestive activity as any movement of the body, arms, hands, head or eyes not related to feeding, drinking or sickness behavior.
In the first set of experiments, the six minute infusion of CCK-8 was started simultaneously with the start of voluntary feeding of the first meal following the usual 16-hour overnight fast. Feeding behavior and plasma glucose, IRI, IRG and PP levels were monitored. In order to examine the CCK-8-induced changes in plasma levels of glucose and pancreatic hormones following a mixed meal independent of the effects of CCK-8 on feeding behavior, a second series of experiments used controlled intragastric infusions of the same liquid diet as was taken orally in the first experiments. The liquid diet was infused at a rate of 10 ml/min for 10 rain (100 kcal total), and plasma levels of glucose, IRI, IRG, and PP were determined at intervals up to 120 min. Consistency between the oral and intragastric studies was maintained by initiating the intragastric infusion of the mixed-meal challenge concurrently with the start of the intravenous infusion of CCK or saline immediately at the end of the monkey's accustomed 16-hour overnight fast.
A univariate, one-sample t-test which allows the testing of the mean of a single sample of observations against an a priori value, (in this case baseline control feeding behavior) was used to describe the within-monkey differences in feeding behavior associated with CCK-8 infusion. For descriptive purposes each feeding parameter (meal size, meal duration. IMI length and total daily intake) for each animal, and CCK experiment, was substituted for the a priori value and compared to a control mean derived from a sampling of the same animal's usual daily eating data (N =9 days). One way analysis of variance (ANOVA) was used to estimate the across monkey differences in feeding behavior as a function of CCK infusions. When significant experimental effects occurred, Scheffe's contrast method was used to identify the specific ways in which the experimental effects contributed to the overall F-ratio [7] . This procedure included the use of protected paired t-tests with a 0.95 Scheffe allowance which compensate for the inflated alpha associated with multiple t-tests. Only the results of the protected t-tests are reported unless otherwise noted. Protected paired t-tests were also used as a basis for describing more specific effects of CCK on plasma glucose, IRI, IRG and PP. Because there were significant between-animal differences in basal levels, the basal level of each peptide or substrate was subtracted from each subsequent value collected over the 120-minute sampling period, thus identifying the total increment above basal levels for each parameter at each time point. Total response area for each parameter from 0 to 120 min was also calculated and the above mentioned analysis procedure using ANOVA and protected paired t-tests was used to identify differences in response areas compared to saline controls.
Glucose and insulin values were standardized to permit further analysis of changes in the insulin/glucose ratio across time and across various CCK-8 doses. The significances of differences in these ratios between CCK doses across animals were determined for each time point by protected paired t-tests. Finally, the initial overall within-animal glucose, insulin, glucagon and pancreatic polypeptide response to the mixed meal stimulus across experimental conditions was determined by profile analysis techniques. Because the obvious differences in the hormones and glucose responses occurred within the first 40 minutes of the experiment, analysis focused on the time period 0-40 minutes. Profile analysis allows the separate testing of (a) the differences between the overall plasma response curves across time for all 4 doses of CCK and saline controls, (b) the differences in the shapes of the response curves (parallelism), and (c) the hypothesis that the curves are flat (plasma levels do not change across time) [7] .
RESULTS

CCK-8 Effect on Feeding Behavior
CCK-8, administered intravenously during the first six minutes of a meal following an overnight fast, has an immediate and significant effect on intrameal pattern at the lowest doses tested (30 ng/kg/min) and temporarily causes cessation of feeding at the highest dose (120 ng/kg/min) in all monkeys studied. The minimal six minute infusion dose required to terminate an ongoing meal following an overnight fast differed between monkeys, ranging from 30 to 120 ng/kg/min.
As shown in Fig. 1 , the usual size of the first meal following an overnight fast in these monkeys ranged from 227 to 281 kcal. The infusion of CCK-8 at a dose of 30 ng/kg/min had no effect on meal size in 3 of 4 monkeys, and maximal suppressive effect in the fourth monkey. An infusion level of 60 ng/kg/min produced near maximal effects on meal size in all but one monkey; the latter required 120 ng/kg/min to produce the cessation of ingestion during the course of a meal. Further, all animals stopped eating within 2 minutes when CCK was infused at a rate of 120 ng/kg/min. In general, meal sizes below 60 kcal reflect the intake during the first 1-2 min of the availability of food. Since CCK-8 infusions were begun simultaneously with the onset of feeding, the CCK effect was not apparent in truncating the ongoing meal until 1-2 min into the feeding period. Thus, for all monkeys, the minimal dose which affected meal size produced a maximal or near maximal reduction in meal size, indicating the abrupt onset of the CCK effect.
Reduction in the duration of the test meal was more sensitive to the effect of CCK, with significant decreases in meal length observed usually at 30 and always at 60 ng/kg/min; further increase in dose resulted in even greater reduction in meal duration: t(16)=-4.9, p<0.001 (Table 1) . The cumulative intakes for one monkey (B-6) at each of three doses of CCK-8 and under saline control conditions are shown in Fig. 2A . Both changes in first meal size and in pattern of feeding are apparent at doses of 60 and 120 ng/kg/min. It is apparent from this figure for a single representative animal, that the rate of feeding was not affected within any single feeding bout, but longer periods of rest or interruptions in feeding were clearly observed. Furthermore, when early interruptions of feeding occurred, the amount taken during the first 40 minutes was reduced ( Fig. 2A) .
COMPARISON OF FIRST MEAL SIZE DURING IV CCK INFUSION TO CONTROLS (~+_SE)
Across monkeys when a meal was either terminated or reduced by CCK-8 infusion, the subsequent inter-meal interval (IMI) was very short--less than 35% of the normal IMI duration for each monkey, or an actual IMI of only 6 to 20 min compared to the usual control IMI (mean±SE) of 155± 16 min (Table 1 ). The amount ingested in the meal immediately following the CCK-8-induced interruption of feeding, when added to the initial feeding amount prior to the onset of the CCK effect, 218__-15 kcal (mean__+SE), generally approximated the total consumed in the usual first meal under control conditions (251±14 kcal): t(8)=-2.2, p=ns. Within the first three hours following the six minute CCK-8 infusion, most animals initiated a second meal, as was their usual pattern, and the food intake had returned to within normal levels for that time period (control=326± 16 kcal as compared to 300± 17 kcal), thus reinforcing the finding of an extremely transient effect of intravenous CCK-8. Total day's intake, and the intake of the subsequent day showed no effect of the short-term CCK-8 infusion compared to saline controls.
In summary, the dose of CCK-8, over a range of 30 to 120 ng/kg/min infused for a six minute period was negatively correlated with the size of the first meal: t(16)=-4.2, p<0.001, the duration of the first meal: t(16)=-4.9, p<0.001, and the duration of the first inter-meal interval: t(15)=-2.5, p<0.03, but had no significant relationship to total food intake for the test day nor for the subsequent day.
CCK-8 Effect on Plasma Glucose Response to a Mixed Meal
As can be seen in Fig. 2B and 2C for one representative animal, CCK-8, infused at rates of 30-120 ng/kg/min, produced an obvious delay in the usual rise in plasma glucose and insulin in response to the oral ingestion of a mixed meal. These delays occurred in both free-feeding animals tested. Because CCK-8 administered during free feeding, as described above, truncated the initial meal, the attentuated glucose and insulin rises could have been associated with the reduced size of the meal load. In order to assess the effect of CCK on glucose and hormone responses to a mixed meal, independent of the effects on feeding behavior and the associated altered intake levels, the same diet, as was normally ingested orally, was infused directly into the stomach via an intragastric tube. A constant volume (100 ml or approximately 100 kcal) was infused at a rate of 10 ml/min. Because some effects on free feeding occurred at CCK-8 infusion levels as low as 30 ng/kg/min, subsequent studies of the effects of CCK-8 on glucose and hormone responses to an intragastric mixed-meal load included a lower dose, 15 ng/kg/min.
Under these conditions of controlled amount and rate of intragastric mixed-meal challenge, CCK-8 still produced apparent delays in the stimulated plasma glucose rise when compared to saline-infused controls (Fig. 3) . During the first 40 minutes of the experiment, profile analysis revealed a significant CCK effect on the plasma glucose response to the intragastric infusion of a mixed meal. This effect was limited to comparisons between saline controls and CCK infused at the rates of 60 and 120 ng/kg/min, F(2,6)=5.7, p<0.05. ANOVA and protected t-tests revealed that at the 10 min point plasma glucose response rise was lower for CCK-8 doses of 30, 60 and 120 ng/kg/min compared to saline controls, F(4,15)=4.3, p<0.02; however, protected t-tests demonstrated that only the difference between saline controls and 120 ng/kg/min exceeded the Scheffe allowance. By the 20 rain and 30 min time points glucose levels had returned toward saline control levels, and were significantly lower only at 20 rain for the 120 ng/kg/min dose, t(8)= I 1.8,p<0.01, and by 40 min, no CCK-8 effect on plasma glucose was significant.
Overall plasma glucose response, based on integration of the glucose levels under the response curve for zero to 120 minutes, was not affected by the 15, 30 or 60 ng/kg/min doses (Fig. 4) . Because of the delayed onset of the glucose response, and the lack of full return to baseline levels by the 120 rain point at the 120 ng/kg/min dose, the glucose response area was significantly smaller than normal saline controis, t(10)=2.9, p<0.02.
CCK-8 Effect on Plasma lnsulin Response to a Mixed Meal
As with plasma glucose, and shown in Fig. 2C for one representative animal, there were delays in the plasma IRI response to intravenous CCK-8 in free-feeding monkeys (N=2). When amount of the meal challenge and rate of delivery were controlled by intragastric infusion of the liquid diet, instead of oral feeding, a similar delay in plasma insulin response was observed (Fig. 5) . Profile analyses revealed a CCK effect on insulin response rise which approached significance when saline controls and CCK-8 infused at the rates of 60 and 120 ng/kg/min were compared, F(2,6)=4,5, p -<0.06. ANOVA demonstrated these differences occurred 
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'oo F 3 . Plasma glucose change from baseline (overnight fasted) levels during the following 10 min intragastric infusion of a mixed meal. CCK-8 was infused intravenously over a 6 min period at four dose levels (N =4 monkeys). The period of CCK infusion is indicated by the stippled area, and the period of the intragastric infusion by the dashed area at the bottom.
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at the 10 and 20 min time points; but when all possible pair combinations were contrasted only the difference between saline controls and CCK infused at 120 ng/kg/min at the 20 min point was significant, t(8)=6.5, p<0.03. This difference did not, however, exceed the Scheffe allowance at the 0.95 level. One change observed in the IRI response did not parallel the changes observed in plasma glucose: following CCK infused at the highest dose (120 ng/kg/min) at the 10 min time period, the mean IRI level of 48.1 IzU/ml was significantly lower than mean basal IRI levels of 67/xU/ml, t(8)=-2.4, p <0.05. By contrast, the 15 ng/kg/min dose produced a slight (non-significant) delay in rise of plasma insulin level at the 5 min point, and possibly enhanced the plasma insulin responses at 10, 20 and 30 min compared to normal saline controls (Fig. 5) , As with glucose, the total insulin response (area under the curve-zero to 120 min) was reduced only by the 120 ng/kg/min dose, t(10)=2.6, p<0.05, and this appeared to be an artifact of the duration of sampling and the lack of samples between the 60 and 120 min time points, when the delayed peak insulin values were undoubtedly reached (Fig. 4) .
The ratio of the standardized values for plasma insulin and plasma glucose showed no significant differences during the 120 min for any CCK-8 dose compared to a normal saline infusion. CCK-8 clearly did not disrupt the close association of plasma glucose and insulin in response to a mixed meal; there was even a slight tendency for CCK-8 at 120 ng/kg/min to strengthen the insulin-glucose relationship, relative to ratios at 15 ng/kg/min or during saline controls. As shown in Table 2 , plasma glucose and insulin levels were highly correlated at all CCK-8 dose levels.
CCK-8 Effect on Plasma Glucagon and Pancreatic Polypeptide Responses to a Mixed Meal
A six min intravenous infusion of CCK-8 had no consistent effect on the response of either plasma glucagon or pancreatic polypeptide to intragastric infusion of a mixed meal (Figs. 6 and 7) . While levels of both hormones were generally higher during CCK-8 infusions, no consistent dose-related effects were observed. Only the 15 ng/kg/min dose produced a significant increase in plasma glucagon--and then only at the 10 min time point. Large variability was observed in these hormone responses.
Non-Feeding Behavior: Effect of CCK-8
Clinical signs of illness during the CCK-8 infusions were not observed. The monkeys showed no retching, vomiting, agitation, unusual drowsiness, or change in stool number or consistency• Maximal likelihood tests of independence demonstrated no CCK-8 dependent differences in behavior between the oral free feeding and the intragastric diet infusion conditions, except for the 120 ng/kg/min dose: the monkeys engaged in significantly more resting behavior at this CCK dose level under the free feeding condition than under tp<0.05, :~p<0.01, §p<0.001 and ¶p<0.0001 when the strength of the product-moment correlation coefficient is tested by the t-statistic. the intragastric diet infusion condition. Monkeys were, in fact, generally more active during the intragastric infusion than while free feeding. There were no other CCKassociated effects on non-ingestive behavior during the 45-minute observation period.
DISCUSSION
Intravenous administration of CCK-8 over a 6 min period coincident with the initiation of free feeding following an overnight fast resulted in a dose-related cessation of the ongoing meal. The threshold for this effect ranged from 30 to 120 ng/kg/min across monkeys, and was apparent within 2 rain of the start of the infusion. In a similar protocol using solid food ingestion by monkeys as the test parameter, Gibbs, Falasco, and McHugh [6] also reported significant suppression of feeding (a 66% decrease) using a dose of CCK slightly larger than our largest dose. Their assessment of feeding behavior was, however, limited to total amount of food taken at the 15, 30, 60 and 120 min time points and early effects would therefore, have been obscured. In all of the monkeys tested in the present study some recovery of feeding has already occurred by the 15 min time point and only the period between 0 and 20 minutes provided sensitive information about the threshold effects of CCK-8.
When a dose of CCK-8, sufficient to transiently terminate feeding, was used we observed no effect on feeding rate either prior to cessation of feeding, or at the time feeding resumed. Anika, Houpt and Houpt [1] reported similar effects on feeding behavior in pigs, however, their doses were probably higher than those we have found to be effective in monkeys.
Our data indicated an extremely rapid and transient time course for the effect of intravenous CCK-8, and support the Gibbs and associated [6] observation that most effects do not extend beyond 15 min after CCK infusion in monkeys. The present data contrast, however, with their finding that monkeys do not compensate for early decreases in food intake following short term CCK administration [6] . However, it should be noted that Gibbs, Falasco and McHugh infused impure CCK, in contrast to the synthetic CCK-8 used in this study. Since practical clinical value may depend upon a residual effect of CCK-8, we looked carefully at the entire 8 hr feeding pattern rates, and intake amounts across time, and total intake on the test day compared to preceding and succeeding days. By 3 hrs post CCK-8 infusion total cumulative intake for the day had returned to control levels indicating that the lean monkeys compensated well for the early and transient decrease in food intake. Neither the total intake for the day, nor the intake on the following day showed any effect of the CCK dose. This contrasts with the report of a residual CCK effect observed over days in man [11], but is similar to H saiso's finding of an absence of prolonged effects of CCK in rats [9] .
This rapid and transient effect of CCK-8 on feeding behavior, combined with our finding of early compensation for the short term depression of food intake probably accounts for the lack of effect of CCK-8 (doses ranging from 1/xg/kg/5 min to 4 t~g/kg/5 min), on food intake in the baboon following an overnight fast [26] . Food intake of the baboon was measured over 30 min after the end of a 5 rain CCK infusion. If baboons are similar to rhesus monkeys within 10 to 20 min following the CCK infusion food intake would have been reinitiated, and since normal meal duration probably approximates 10 min, it is not surprising that no reliable effect of CCK on food intake was observed at the 30 min time point [26] .
As we have found in monkeys, Hsiao and others [9] and Mueller and Hsiao [21] , using similar protocols in rats, showed a significant CCK effect on truncating the size of a meal, and no effect on rate of feeding. In both the monkeys and rats, the shortened IMI after the truncated first meal probably related to the reduced meal size, and not to any early disinhibition of feeding.
As described by Gibbs, Falasco and McHugh [6] and Falasco, Smith and Gibbs [3] , monkeys showed no signs of illness or distress during CCK infusions. Specific observation of types of behavior changes elicited during the first 30 minutes showed the same increase in resting behavior as was described by Falasco, Smith and Gibbs [3] . Whether the decrease in food intake with CCK-8 is related to any mild sensations of malaise or other non-specific effects of CCK is difficult to ascertain.
Behavioral monitoring of the monkeys suggested that under the free feeding conditions at the largest dose, CCK-8 produced significantly more resting behavior compared to saline. That this might be related to the combination of CCK plus pregastric factors was suggested by the finding that behavior during the CCK plus intragastric meal infusion did not differ from saline plus the intragastric meal. Thus some pregastric stimuli may be necessary for the CCK-associated satiety behavior to occur. Antin, Gibbs and Smith [2] , and Kraly and others [12] using sham-fed rats found a synergism between CCK and pregastric factors, suggesting complementary roles in producing satiety behavior.
In the present studies, the rise of plasma glucose during the course of ingestion or infusion of a mixed meal was significantly delayed during CCK-8 infusions, but total glucose response in the post infusion period was unaffected by the preceding CCK. Using intraperitoneal CCK-8 doses five times higher than our largest cumulative intravenous dose, McLaughlin and Baile [18] found decreased glucose response to a meal for at least 60 minutes in obese and lean rats. With doses 1.5 to six times greater than ours, Woods and Stein [26] found that CCK-8 reliably attenuated the glucose response to the subsequent meal at the time point 30 min after the start of the meal. The highest dose used for our monkeys also showed significant suppression of the glucose response. Our data show, however, that this is a dose dependent delay, and not an attenuation of response since the integrated glucose area or incremental area calculated to 120 min was normal except for the highest dose where glucose had not yet returned to basal levels at the 120 min time point. In light of Moran and McHugh's demonstration (using approximately 1/10 of our CCK-8 dose) that CCK-8 consistently produced rapid and transient delay or slowing of gastric emptying [20] , a possible explanation is that the doserelated delay in plasma glucose response to a mixed meal is a direct function of the slowed gastric emptying.
The doses of CCK used in these experiments were considerably larger than those producing contraction of the gall bladder in humans and baboons [13] , and the observed effects of CCK-8 are, therefore, possibly pharmacological. Although the physiological role of CCK in appetite regulation is open to question at least until postprandial plasma CCK levels can be ascertained and its release from intestinal sites selectively inhibited, it may very well act in concert with other satiety-affecting factors. Its apparent short time course of action, the occurrence of gastrointestinal side effects at high doses, the decreased sensitivity of obese Zucker rats to its satiety effect [16] and possible habituation over time [19] may limit the therapeutic potential as an appetite suppressant.
Our studies of intravenous CCK-8 effects on plasma insulin and glucagon levels in awake, mixed meal-stimulated monkeys differs from the effects observed by Rouiller and associates [23] in anesthetized dogs. Infusing CCK-8 over a longer period, but at a dose rate equivalent to 30 ng/kg/min, they reported significant and rapid (within 5 min) rises in plasma insulin and glucagon, with incremental values significantly higher than for saline controls [23] . One might expect that the superimposing of a mixed meal on top of the CCK-8 infusion would produce at least as rapid and significant a rise in insulin as was observed for CCK-8 alone in the anesthetized dog. This was clearly not true for our monkeys where the rise in plasma insulin was significantly delayed (more than 15 minutes) by the CCK-8 infusion at all doses larger than 15 ng/kg/min.
Frame and associates [5] have proposed that CCK stimulates the "quick release" pool of insulin, however, the doses of CCK used in our monkeys failed to produce this effect. Instead, our data are in accord with the findings of Jensen and others [10] using the isolated perfused porcine pancreas, in that CCK-8 did not significantly stimulate the secretion of insulin.
CCK may stimulate glucagon release, but the effect is small. Neither the mixed meal nor the intravenous CCK produced a significant change in plasma glucagon levels, although comparisons to saline controls suggested some variable increases. This again, contrasts with the immediate large stimulation of glucagon release during CCK-8 infusions in the anesthetized dog [23] . Species and protocol differences, including differences in time points for response measurement, the type and molecular form of the CCK used and CCK dose all confound the interpretation of these diverse findings.
Lonovics et al. [15] have shown in dogs that CCK-8 produced an effect on plasma levels of pancreatic polypeptide similar to the effect of ingestion of a mixed meal, and have suggested that CCK may be an important mediator of PP release. Our results suggest that exogenous CCK may produce a small additive effect on the PP response to a mixed meal. Although variability prevented the finding of significant enhancement by CCK, PP was consistently higher during CCK infusion with a mixed meal when compared to saline infusion. Even where there was a probable delay in test meal absorption as indicated by the delay in plasma glucose rise, pancreatic polypeptide showed an early rise and remained above control levels. There was, however, no observable dose-response relationship.
In summary, intravenous CCK-8 infused during the first 6 min of an oral or intragastric mixed meal in monkeys produced significant dose related inhibition of feeding behavior, delayed but did not otherwise alter the plasma glucose and insulin responses, variably enhanced (not significantly) the release of glucagon and pancreatic polypeptide, and had no effects extending beyond 3 hours. Despite the consistent delays in plasma glucose and insulin responses to a mixed meal at all CCK-8 infusion rates greater than 15 ng/kg/min, the minimal effective dose for feeding inhibition varied from 30 to 120 ng/kg/min in the same monkeys. This finding suggests that the CCK-induced delays in plasma insulin and glucose response are not sufficient to the feeding effect. Clearly, insulin did not mediate the CCK-8-induced decrement in food intake, although delay of the early insulin response to a meal may be necessary to the effect on feeding. The usual close relationship between plasma glucose and insulin levels in response to a mixed meal was not significantly changed by the administration of intravenous CCK.
